Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Capital Employed (2016 - 2025)

Adma Biologics (ADMA) has disclosed Return on Capital Employed for 13 consecutive years, with 0.36% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed changed 0.0% year-over-year to 0.36%, compared with a TTM value of 0.36% through Dec 2025, changed 0.0%, and an annual FY2025 reading of 0.39%, changed 0.0% over the prior year.
  • Return on Capital Employed was 0.36% for Q4 2025 at Adma Biologics, up from 0.33% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.36% in Q4 2025 and bottomed at 0.32% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.03%, with a median of 0.03% recorded in 2023.
  • The sharpest move saw Return on Capital Employed dropped -3bps in 2021, then surged 33bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.26% in 2021, then surged by 46bps to 0.14% in 2022, then surged by 154bps to 0.07% in 2023, then surged by 384bps to 0.36% in 2024, then rose by 0bps to 0.36% in 2025.
  • Business Quant data shows Return on Capital Employed for ADMA at 0.36% in Q4 2025, 0.33% in Q3 2025, and 0.34% in Q2 2025.